Trifork Group AG
40/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
40/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
Company announcement no. 40 / 2024
Schindellegi, Switzerland – 6 December 2024
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by a person or entity closely associated with a person discharging managerial responsibilities in Trifork.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Jørn Larsen | |
| 2. | Reason for the notification | ||
| a) | Position/status | CEO | |
| b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Trifork Group AG | |
| b) | LEI | 8945004BYZKXPESTBL36 | |
| 4.1 | Details of the transaction(s) | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares ISIN CH1111227810 | |
| b) | Nature of the transaction | Transfer of shares to Blackbird II ApS, a company 100% owned and controlled by Jørn Larsen | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 80.00 | 95,000 | ||
| d) | Aggregated information
| Aggregated volume: 95,000 Price: DKK 80.00 Total value: DKK 7,600,000.00 | |
| e) | Date of the transaction | 5 December 2024 | |
| f) | Place of the transaction | OTC off-exchange | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Blackbird II ApS | |
| 2. | Reason for the notification | ||
| a) | Position/status | Closely associated person to Jørn Larsen, CEO of Trifork Group AG | |
| b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Trifork Group AG | |
| b) | LEI | 8945004BYZKXPESTBL36 | |
| 4.1 | Details of the transaction(s) | ||
| a) | Description of the financial instrument, type of instrument Identification code | Shares ISIN CH1111227810 | |
| b) | Nature of the transaction | Transfer of shares from Jørn Larsen’s private shareholding | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 80.00 | 95,000 | ||
| d) | Aggregated information
| Aggregated volume: 95,000 Price: DKK 80.00 Total value: DKK 7,600,000.00 | |
| e) | Date of the transaction | 5 December 2024 | |
| f) | Place of the transaction | OTC off-exchange | |
For more information, please contact:
Frederik Svanholm, Group Investment Director & Head of IR
frsv@trifork.com, +41 79 357 7317
About Trifork Group
Trifork is a pioneering global technology partner, empowering enterprise and public sector customers with innovative solutions. With 1,278 professionals across 76 business units in 15 countries, Trifork delivers expertise in inspiring, building, and running advanced software solutions across diverse sectors, including public administration, healthcare, manufacturing, logistics, energy, financial services, retail, and real estate. Trifork Labs, the Group’s R&D hub, drives innovation by investing in and developing synergistic and high-potential technology companies. Trifork Group AG is a publicly listed company on Nasdaq Copenhagen. Learn more at trifork.com.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd16.9.2025 22:30:00 CEST | Press release
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
Society of Actuaries16.9.2025 20:46:16 CEST | Press release
Society of Actuaries Announces Planned CEO Succession in 2026
Lehman Brothers UK Capital Funding LP16.9.2025 17:53:36 CEST | Press release
Lehman Brothers UK Capital Funding LP: Notice of Proposed Interim Payment
Sampo plc16.9.2025 17:10:00 CEST | Press release
Sampo prices the issuance of new Restricted Tier 1 notes
Ringkjøbing Landbobank A/S16.9.2025 17:00:58 CEST | Pressemeddelelse
Ringkjøbing Landbobank udsteder Tier 2-kapital
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom